SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported):
March 26, 1999 (March 25, 1999)
Quest Diagnostics Incorporated
(Exact name of registrant as specified in its charter)
DELAWARE 1-12215 16-1387862
(State or other jurisdiction (Commission File Number) (I.R.S. Employer
of incorporation) Identification No.)
One Malcolm Avenue, Teterboro, New Jersey 07608
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (201) 393-5000
<PAGE>
Item 5. Other Events
The waiting period under the Hart-Scott-Rodino Antitrust
Improvements Act of 1976, as amended, expired on March 25, 1999, at 11:59 p.m.,
with respect to Quest Diagnostics Incorporated's proposed acquisition of the
clinical laboratory operations of SmithKline Beecham plc
<PAGE>
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
March 26, 1999
Quest Diagnostics Incorporated
By: /s/ Raymond C. Marier
Raymond C. Marier
Vice President and General Counsel
